These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 23882081)

  • 21.
    Stüve P; Minarrieta L; Erdmann H; Arnold-Schrauf C; Swallow M; Guderian M; Krull F; Hölscher A; Ghorbani P; Behrends J; Abraham WR; Hölscher C; Sparwasser TD; Berod L
    Front Immunol; 2018; 9():495. PubMed ID: 29675017
    [No Abstract]   [Full Text] [Related]  

  • 22. Macrophage migration inhibitory factor reduces the growth of virulent Mycobacterium tuberculosis in human macrophages.
    Oddo M; Calandra T; Bucala R; Meylan PR
    Infect Immun; 2005 Jun; 73(6):3783-6. PubMed ID: 15908412
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Engagement of the Aryl Hydrocarbon Receptor in Mycobacterium tuberculosis-Infected Macrophages Has Pleiotropic Effects on Innate Immune Signaling.
    Memari B; Bouttier M; Dimitrov V; Ouellette M; Behr MA; Fritz JH; White JH
    J Immunol; 2015 Nov; 195(9):4479-91. PubMed ID: 26416282
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular cloning and functional characterization of the avian macrophage migration inhibitory factor (MIF).
    Kim S; Miska KB; Jenkins MC; Fetterer RH; Cox CM; Stuard LH; Dalloul RA
    Dev Comp Immunol; 2010 Sep; 34(9):1021-32. PubMed ID: 20470818
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cutting edge: Toll-like receptor (TLR)2- and TLR4-mediated pathogen recognition in resistance to airborne infection with Mycobacterium tuberculosis.
    Reiling N; Hölscher C; Fehrenbach A; Kröger S; Kirschning CJ; Goyert S; Ehlers S
    J Immunol; 2002 Oct; 169(7):3480-4. PubMed ID: 12244136
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduction of the aortic inflammatory response in spontaneous atherosclerosis by blockade of macrophage migration inhibitory factor (MIF).
    Burger-Kentischer A; Göbel H; Kleemann R; Zernecke A; Bucala R; Leng L; Finkelmeier D; Geiger G; Schaefer HE; Schober A; Weber C; Brunner H; Rütten H; Ihling C; Bernhagen J
    Atherosclerosis; 2006 Jan; 184(1):28-38. PubMed ID: 15921687
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Macrophage migration inhibitory factor enzymatic activity, lung inflammation, and cystic fibrosis.
    Adamali H; Armstrong ME; McLaughlin AM; Cooke G; McKone E; Costello CM; Gallagher CG; Leng L; Baugh JA; Fingerle-Rowson G; Bucala RJ; McLoughlin P; Donnelly SC
    Am J Respir Crit Care Med; 2012 Jul; 186(2):162-9. PubMed ID: 22592805
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Macrophage migration inhibitory factor (MIF) controls cytokine release during respiratory syncytial virus infection in macrophages.
    de Souza GF; Muraro SP; Santos LD; Monteiro APT; da Silva AG; de Souza APD; Stein RT; Bozza PT; Porto BN
    Inflamm Res; 2019 Jun; 68(6):481-491. PubMed ID: 30944975
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential requirement of formyl peptide receptor 1 in macrophages and neutrophils in the host defense against Mycobacterium tuberculosis Infection.
    Nafiz TN; Sankar P; Mishra LK; Rousseau RP; Saqib M; Subbian S; Parihar SP; Mishra BB
    Sci Rep; 2024 Oct; 14(1):23595. PubMed ID: 39384825
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ipr1 gene mediates innate immunity to tuberculosis.
    Pan H; Yan BS; Rojas M; Shebzukhov YV; Zhou H; Kobzik L; Higgins DE; Daly MJ; Bloom BR; Kramnik I
    Nature; 2005 Apr; 434(7034):767-72. PubMed ID: 15815631
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acylation determines the toll-like receptor (TLR)-dependent positive versus TLR2-, mannose receptor-, and SIGNR1-independent negative regulation of pro-inflammatory cytokines by mycobacterial lipomannan.
    Doz E; Rose S; Nigou J; Gilleron M; Puzo G; Erard F; Ryffel B; Quesniaux VF
    J Biol Chem; 2007 Sep; 282(36):26014-25. PubMed ID: 17617634
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Migration inhibitory factor (MIF) released by macrophages upon recognition of immune complexes is critical to inflammation in Arthus reaction.
    Paiva CN; Arras RH; Magalhães ES; Alves LS; Lessa LP; Silva MH; Ejzemberg R; Canetti C; Bozza MT
    J Leukoc Biol; 2009 May; 85(5):855-61. PubMed ID: 19188484
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Macrophage migration inhibitory factor (MIF): a key player in protozoan infections.
    Rosado Jde D; Rodriguez-Sosa M
    Int J Biol Sci; 2011; 7(9):1239-56. PubMed ID: 22110378
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Macrophage migration inhibitory factor (MIF) sustains macrophage proinflammatory function by inhibiting p53: regulatory role in the innate immune response.
    Mitchell RA; Liao H; Chesney J; Fingerle-Rowson G; Baugh J; David J; Bucala R
    Proc Natl Acad Sci U S A; 2002 Jan; 99(1):345-50. PubMed ID: 11756671
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Innate cellular sources of interleukin-17A regulate macrophage accumulation in cigarette- smoke-induced lung inflammation in mice.
    Bozinovski S; Seow HJ; Chan SP; Anthony D; McQualter J; Hansen M; Jenkins BJ; Anderson GP; Vlahos R
    Clin Sci (Lond); 2015 Nov; 129(9):785-96. PubMed ID: 26201093
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Migration inhibitory factor induces killing of Leishmania major by macrophages: dependence on reactive nitrogen intermediates and endogenous TNF-alpha.
    Jüttner S; Bernhagen J; Metz CN; Röllinghoff M; Bucala R; Gessner A
    J Immunol; 1998 Sep; 161(5):2383-90. PubMed ID: 9725234
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elevated levels of serum macrophage migration inhibitory factor in patients with pulmonary tuberculosis.
    Yamada G; Shijubo N; Takagi-Takahashi Y; Nishihira J; Mizue Y; Kikuchi K; Abe S
    Clin Immunol; 2002 Aug; 104(2):123-7. PubMed ID: 12165273
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MIF contributes to Trypanosoma brucei associated immunopathogenicity development.
    Stijlemans B; Leng L; Brys L; Sparkes A; Vansintjan L; Caljon G; Raes G; Van Den Abbeele J; Van Ginderachter JA; Beschin A; Bucala R; De Baetselier P
    PLoS Pathog; 2014 Sep; 10(9):e1004414. PubMed ID: 25255103
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of macrophage migration inhibitory factor in the Th2 immune response to epicutaneous sensitization.
    Das R; Moss JE; Robinson E; Roberts S; Levy R; Mizue Y; Leng L; McDonald C; Tigelaar RE; Herrick CA; Bucala R
    J Clin Immunol; 2011 Aug; 31(4):666-80. PubMed ID: 21559932
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative analysis of T lymphocytes recovered from the lungs of mice genetically susceptible, resistant, and hyperresistant to Mycobacterium tuberculosis-triggered disease.
    Lyadova IV; Eruslanov EB; Khaidukov SV; Yeremeev VV; Majorov KB; Pichugin AV; Nikonenko BV; Kondratieva TK; Apt AS
    J Immunol; 2000 Nov; 165(10):5921-31. PubMed ID: 11067954
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.